Bouhtit F - Search Results

1

Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction.

Moussa Agha D, Rouas R, Najar M, Bouhtit F, Fayyad-Kazan H, Lagneaux L, Bron D, Meuleman N, Lewalle P, Merimi M. Moussa Agha D, et al. Among authors: bouhtit f. Cells. 2020 Sep 8;9(9):2053. doi: 10.3390/cells9092053. Cells. 2020. PMID: 32911844 Free PMC article.

2

Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs.

Moussa Agha D, Rouas R, Najar M, Bouhtit F, Naamane N, Fayyad-Kazan H, Bron D, Meuleman N, Lewalle P, Merimi M. Moussa Agha D, et al. Among authors: bouhtit f. Int J Mol Sci. 2020 Sep 25;21(19):7065. doi: 10.3390/ijms21197065. Int J Mol Sci. 2020. PMID: 32992819 Free PMC article.

3

New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways.

Bouhtit F, Najar M, Moussa Agha D, Melki R, Najimi M, Sadki K, Boukhatem N, Bron D, Meuleman N, Hamal A, Lagneaux L, Lewalle P, Merimi M. Bouhtit F, et al. Molecules. 2021 Jan 14;26(2):410. doi: 10.3390/molecules26020410. Molecules. 2021. PMID: 33466806 Free PMC article.

4

Empowering the immune fate of bone marrow mesenchymal stromal cells: gene and protein changes.

Najar M, Ouhaddi Y, Bouhtit F, Melki R, Afif H, Boukhatem N, Merimi M, Fahmi H. Najar M, et al. Among authors: bouhtit f. Inflamm Res. 2019 Feb;68(2):167-176. doi: 10.1007/s00011-018-1198-8. Epub 2018 Nov 14. Inflamm Res. 2019. PMID: 30426152

5

Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges.

Najar M, Bouhtit F, Melki R, Afif H, Hamal A, Fahmi H, Merimi M, Lagneaux L. Najar M, et al. Among authors: bouhtit f. J Clin Med. 2019 May 8;8(5):626. doi: 10.3390/jcm8050626. J Clin Med. 2019. PMID: 31071990 Free PMC article.

6

The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings.

Merimi M, El-Majzoub R, Lagneaux L, Moussa Agha D, Bouhtit F, Meuleman N, Fahmi H, Lewalle P, Fayyad-Kazan M, Najar M. Merimi M, et al. Among authors: bouhtit f. Front Cell Dev Biol. 2021 Aug 18;9:661532. doi: 10.3389/fcell.2021.661532. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34490235 Free PMC article. Review.

7

Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.

Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M. Najar M, et al. Among authors: bouhtit f. Front Cell Dev Biol. 2022 Jan 14;9:716853. doi: 10.3389/fcell.2021.716853. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35096805 Free PMC article. Review.

8

Fundamental and Applied Advances in Stem Cell Therapeutic Research.

Merimi M, Rahmani S, Afailal Tribak A, Bouhtit F, Fahmi H, Najar M. Merimi M, et al. Among authors: bouhtit f. Cells. 2022 Jun 20;11(12):1976. doi: 10.3390/cells11121976. Cells. 2022. PMID: 35741105 Free PMC article.

9

The biological response of mesenchymal stromal cells to thymol and carvacrol in comparison to their essential oil: An innovative new study.

Bouhtit F, Najar M, Agha DM, Melki R, Najimi M, Sadki K, Lewalle P, Hamal A, Lagneaux L, Merimi M. Bouhtit F, et al. Food Chem Toxicol. 2019 Dec;134:110844. doi: 10.1016/j.fct.2019.110844. Epub 2019 Sep 25. Food Chem Toxicol. 2019. PMID: 31562950

10

Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic.

Merimi M, Lewalle P, Meuleman N, Agha DM, El-Kehdy H, Bouhtit F, Ayoub S, Burny A, Fahmi H, Lagneaux L, Najar M. Merimi M, et al. Among authors: bouhtit f. J Clin Med. 2021 Feb 25;10(5):905. doi: 10.3390/jcm10050905. J Clin Med. 2021. PMID: 33668878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters